Ruth Koscielak is a female broadcasting pioneer and one of the most well
known radio personalities in the Upper Midwest. She has been hosting a
midday talk show for more than 20 years and currently airs afternoons on
Monday through Friday on Minnesota affiliates WEZU AM 1220 of Stillwater,
KDAL AM 610 of Duluth, KDWA AM 1460 of Hastings and KRWC AM 1360 of Wright
County.
“With the stories in the news of heart attacks, strokes and diabetes in
younger and younger people, it makes sense to find out your risk for
cardiovascular disease before it’s too late,” said Ruth Koscielak. “We are
looking forward to having Dr. Stephen L. Zuckerman, head of internal
medicine at Aspen Medical Group’s East Lake Street Clinic in Minneapolis,
join us at the fair to talk to our listeners further about the importance
of early detection of cardiovascular disease and how the CVProfilor®
System helps meet this goal,” added Koscielak.
“Since more women die from cardiovascular disease each year than men and
since the majority of Ruth’s listeners are women, this presents an
excellent opportunity to provide further education on cardiovascular risk
factors and the importance of early detection,” said Dr. Zuckerman. “The
CVProfilor® System has proven to be a valuable tool in my daily
clinical practice. I use it nearly every day on patients who are at risk
for cardiovascular disease since these patients cannot be adequately
assessed with just blood pressure measurements. The CVProfilor®
System provides information on my patients’ arterial health that I cannot
obtain by any other means and I believe that in the next few years, the
measurement of arterial elasticity will become as common as a blood
pressure reading. It’s that clinically important,” added Dr. Zuckerman.
Hypertension Diagnostics, Inc. designs, develops, manufactures and markets
proprietary cardiovascular profiling systems for medical applications and
clinical research. These systems are marketed to physicians, other health
care professionals and researchers by a direct sales force and via
distributors throughout the world. In addition to providing blood pressure
values, the systems non-invasively detect subtle changes in the compliance
or elasticity of both large and small arteries which is a unique feature
of HDI’s technology.
Forward-looking statements in this press release are made under the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
The Company wishes to caution readers not to place undue reliance on any
forward-looking statements and to recognize that the statements are not a
prediction of actual future results. Actual results could differ
materially from those presented and anticipated in the forward-looking
statements due to the risks and uncertainties set forth in the Company’s
2001 Annual Report on Form 10-KSB under the caption “Risk Factors,” as
well as others not now anticipated.
CVProfilor is a registered trademark of Hypertension Diagnostics, Inc.
Hypertension Diagnostics, HDI/PulseWave, PulseWave and CVProfile are trademarks of
Hypertension Diagnostics, Inc. All rights reserved.
Contact: Greg H. Guettler, President
